MedPath

ITOVEBI

ITOVEBI

Approved
DIN Number

02555476

Drug Class

Human

Market Date

Apr 10, 2025

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02555476
AIG Number0166524001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription Recommended
A
ATC Code
L01EX OTHER PROTEIN KINASE INHIBITORS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

INAVOLISIBActive
Strength: 3 MG
Monograph: INAVOLISIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.